学术探索
学术期刊
新闻热点
数据分析
智能评审

长效β2受体激动剂在慢性阻塞性肺疾病中的应用

被引：16
作者：
叶丽川
刘春涛
机构：
[1] 四川大学华西医院呼吸内科
来源：
中国呼吸与危重监护杂志 | 2003年 / 04期
关键词：
慢性阻塞性肺疾病; COPD; 福莫特罗; 沙美特罗; 受体; 激动剂;
D O I：
暂无
中图分类号：
R563.9 [其他];
学科分类号：
摘要：
引用
收藏
页码：65 / 68
页数：4
相关论文
共 5 条
  • [1] Oral bambuterol compared to inhaled salmeterol in patients with partially reversible chronic obstructive pulmonary disease
    Cazzola, M
    Calderaro, F
    Califano, C
    Di Pema, F
    Vinciguerra, A
    Donner, CF
    Matera, MG
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1999, 54 (11) : 829 - 833
  • [2] Long termtreatmentwithinhaledbudesonideinpersonswithmildchronicobstructivepulmonarydiseseasewhocontinuesmoking.EueopeanRespiratorySocietyStudyonChronicObstructivePulmonaryDisease. PauwelsRA ,LofdahlC ,LaitinenLA ,etal. The New England Journal of Medicine . 1999
  • [3] Effectiveness of fluticasone propionate and salmeterol combination delivered via the Diskus device in the treatment of chronic obstructive pulmonary disease. Mahler DA, Wire P, Horstman D, et al. American Journal of Respiratory and Critical Care Medicine . 2002
  • [4] Economic burden of chronic obstructive pulmonary disease.Impact of new treatment options. Friedman M, Hilleman DE. Pharmacoeconomics . 2001
  • [5] FormoterolinChronicObstructivePul monaryDisease（FICOPD）IIStudyGroup.Comparisonoftheefficacy,tolera bility,andsafetyofformoteroldrypowderandoral,slow releasetheophyllineinthetreatmentofCOPD. RossiA ,KristufekP ,LevineBE ,etal. Chest . 2002
1